Variants in promoter and UTR regions might also have a potential as phenotype modifiers, since animal models have already shown that high levels of EGFR expression modify the initiation of neurofibromas, increasing their numbers [54]. This evidence concerns the gene EGFR and plexiform neurofibroma.